|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-31
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the safety and efficacy of abatacept, a selective T cell costimulation modulator, in patients with psoriatic arthritis (PsA).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1529-0131
|
|
pubmed:author |
pubmed-author:BaharyOrnaO,
pubmed-author:BeckerJean-ClaudeJC,
pubmed-author:GenoveseMark CMC,
pubmed-author:GladmanDafnaD,
pubmed-author:GladsteinGeoffreyG,
pubmed-author:KivitzAlan JAJ,
pubmed-author:MeasePhilipP,
pubmed-author:ParrotPP,
pubmed-author:RitchlinChristopherC,
pubmed-author:SheilaKellyK,
pubmed-author:SigalLeonardL,
pubmed-author:TengJulieJ,
pubmed-author:WollenhauptJürgenJ
|
|
pubmed:copyrightInfo |
Copyright © 2011 by the American College of Rheumatology.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
939-48
|
|
pubmed:meshHeading |
pubmed-meshheading:21128258-Adult,
pubmed-meshheading:21128258-Antirheumatic Agents,
pubmed-meshheading:21128258-Arthritis, Psoriatic,
pubmed-meshheading:21128258-CD4-Positive T-Lymphocytes,
pubmed-meshheading:21128258-CD8-Positive T-Lymphocytes,
pubmed-meshheading:21128258-Dose-Response Relationship, Drug,
pubmed-meshheading:21128258-Double-Blind Method,
pubmed-meshheading:21128258-Female,
pubmed-meshheading:21128258-Humans,
pubmed-meshheading:21128258-Immunoconjugates,
pubmed-meshheading:21128258-Magnetic Resonance Imaging,
pubmed-meshheading:21128258-Male,
pubmed-meshheading:21128258-Middle Aged,
pubmed-meshheading:21128258-Outcome Assessment (Health Care),
pubmed-meshheading:21128258-Quality of Life,
pubmed-meshheading:21128258-Severity of Illness Index,
pubmed-meshheading:21128258-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.
|
|
pubmed:affiliation |
University of Washington, Seattle, WA, USA. pmease@nwlink.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
